Evidence-Based Practice Recommendations
Prescribing Opioids, Providing Naloxone, and Preventing Drug Diversion: The West Virginia Requirement
Course #91603 - $18-
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.
Before starting and periodically during continuation of opioid therapy, the Centers for Disease Control and Prevention recommends clinicians evaluate risk for opioid-related harms and discuss risk with patients. Clinicians should work with patients to incorporate into the management plan strategies to mitigate risk, including offering naloxone
(https://www.cdc.gov/mmwr/volumes/71/rr/rr7103a1.htm Last Accessed: April 18, 2023)Strength of Recommendation/Level of Evidence: A4 (Most patients should receive the recommended course of action based on clinical experience and observations, observational studies with important limitations, or randomized clinical trials with several major limitations.)
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.